Asensus Surgical Investors Need To Take Long-Term View on Its Technology
Asensus claims its Senhance can do a hysterectomy for half what Intuitive's DaVinci robot costs, with renewable instruments and haptic feedback. The long haul is the only way to play ASXC stock.More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner
Source: msn.com